Hazem Hassan

Dr. Hazem E. Hassan is an Assistant Professor of Clinical Pharmacology and Pharmacometrics and Director of PharDSC_4351_newmacokinetics and Biopharmaceutics Laboratory (PBL), School of Pharmacy, University of Maryland (UMSOP). He received his B. Pharm degree (Summa Cum Laude) from Faculty of Pharmacy, Helwan University, Egypt. Then he joined UMSOP where he received his doctorate degree (Clin. Pharmacol and DMPK), his post-doctoral training (Clin. Pharmacol.) and then his Masters degree (Pharmacometrics). Dr. Hassan has more than 14 years of experience in the field of clinical pharmacology, DMPK and drug development.  Dr. Hassan is a registered/certified controlled dangerous substances researcher by the State of Maryland and the US Department of Justice division of Drug Enforcement Administration (DEA). Dr. Hassan appreciates volunteering opportunities in many national organizations and is actively serving on different capacities on ASCPT, AAPS, ACCP and AACP committees (QP, DDDI, Educational and Pharmaceutics committees, respectively) and is currently the Co-Leader of the ASCPT-QP Hot Topics Initiative. Dr. Hassan received several national/international awards including the American Association of Pharmaceutical Scientists (AAPS) award in Pharmacokinetics, Pharmacodynamics, and Drug Metabolism/Clinical Sciences (PPDM/CS), Dr. Ralph Shangrow award, Dr. Arthur Shwartz award and the Egyptian Government General Mission award. In 2004, he was inducted as a Rho Chi Honor Society Member and he currently has a joint appointment as an Associate Professor of Pharmaceutics in Faculty of Pharmacy, Helwan University, Egypt. Dr. Hassan is passionate about his research program and takes pride of being an active registered pharmacist by the American National Association of Boards of Pharmacy (nabp).